Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.

Vaitkiene P, Valiulyte I, Glebauskiene B, Liutkeviciene R.

Diagn Pathol. 2017 Apr 8;12(1):33. doi: 10.1186/s13000-017-0622-7.

2.

Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?

Glebauskiene B, Liutkeviciene R, Vilkeviciute A, Kriauciuniene L, Jakstiene S, Zlatkute E, Tamosiunas A, Zemaitiene R, Vaitkiene P, Zaliuniene D.

Dis Markers. 2017;2017:5839528. doi: 10.1155/2017/5839528. Epub 2017 Jan 17.

3.

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma.

Steponaitis G, Kazlauskas A, Skiriute D, Valiulyte I, Skauminas K, Tamasauskas A, Vaitkiene P.

Oncol Lett. 2016 Nov;12(5):3305-3311. Epub 2016 Sep 1.

4.

MMP-14 and TGFβ-1 methylation in pituitary adenomas.

Ruskyte K, Liutkevicienė R, Vilkeviciute A, Vaitkiene P, Valiulytė I, Glebauskiene B, Kriauciuniene L, Zaliuniene D.

Oncol Lett. 2016 Oct;12(4):3013-3017. Epub 2016 Jul 29.

5.

High CHI3L1 expression is associated with glioma patient survival.

Steponaitis G, Skiriutė D, Kazlauskas A, Golubickaitė I, Stakaitis R, Tamašauskas A, Vaitkienė P.

Diagn Pathol. 2016 Apr 27;11:42. doi: 10.1186/s13000-016-0492-4.

6.

High level of Sema3C is associated with glioma malignancy.

Vaitkienė P, Skiriutė D, Steponaitis G, Skauminas K, Tamašauskas A, Kazlauskas A.

Diagn Pathol. 2015 Jun 2;10:58. doi: 10.1186/s13000-015-0298-9.

7.

Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome.

Skiriutė D, Steponaitis G, Vaitkienė P, Mikučiūnas M, Skauminas K, Tamašauskas A, Kazlauskas A.

J Cancer. 2014 May 13;5(6):446-56. doi: 10.7150/jca.9140. eCollection 2014.

8.

Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.

Skiriutė D, Vaitkienė P, Ašmonienė V, Steponaitis G, Deltuva VP, Tamašauskas A.

J Neurooncol. 2013 Jul;113(3):441-9. doi: 10.1007/s11060-013-1133-3. Epub 2013 Apr 28.

PMID:
23624749
9.

GATA4 and DcR1 methylation in glioblastomas.

Vaitkienė P, Skiriutė D, Skauminas K, Tamašauskas A.

Diagn Pathol. 2013 Jan 15;8:7. doi: 10.1186/1746-1596-8-7.

10.

Associations between TFPI-2 methylation and poor prognosis in glioblastomas.

Vaitkienė P, Skiriutė D, Skauminas K, Tamašauskas A.

Medicina (Kaunas). 2012;48(7):345-9.

11.

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.

Skiriute D, Vaitkiene P, Saferis V, Asmoniene V, Skauminas K, Deltuva VP, Tamasauskas A.

BMC Cancer. 2012 Jun 6;12:218. doi: 10.1186/1471-2407-12-218.

Supplemental Content

Loading ...
Support Center